Quantitative Cortex-Based Mapping With Hybrid 18F-FDG-PET/MR Images in MRI-Negative Epilepsy

IF 4.8 1区 医学 Q1 NEUROSCIENCES
Chao Zhang, Zhenming Wang, Yihe Wang, Hang Cao, Liankun Ren, Tao Yu, Yong-Zhi Shan, Xiaosong He, John S. Duncan, Jie Lu, Penghu Wei, Guoguang Zhao
{"title":"Quantitative Cortex-Based Mapping With Hybrid 18F-FDG-PET/MR Images in MRI-Negative Epilepsy","authors":"Chao Zhang,&nbsp;Zhenming Wang,&nbsp;Yihe Wang,&nbsp;Hang Cao,&nbsp;Liankun Ren,&nbsp;Tao Yu,&nbsp;Yong-Zhi Shan,&nbsp;Xiaosong He,&nbsp;John S. Duncan,&nbsp;Jie Lu,&nbsp;Penghu Wei,&nbsp;Guoguang Zhao","doi":"10.1111/cns.70336","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>Localization of the network underlying drug-resistant focal epilepsy in individuals considering surgical treatment with unremarkable MRI is challenging. Concordance rates of 40%–69% have been reported with FDG-PET image statistical parametric mapping (SPM). We investigated the efficacy of postprocessing specific to cortices by cortex-based mapping (CBM) on hybrid PET/MR images with healthy subjects to localize sites of seizure onset.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We retrospectively examined the PET/MR images of 42 MRI-negative individuals with drug-resistant focal epilepsy who had surgery and 23 healthy subjects. Visual interpretation of standardized uptake value ratios (SUVRs), voxelwise mapping with a two-sample <i>t</i>-test of SUVRs (t-map, SPM), and the proposed z-transformation of the SUVR of patients compared with those of healthy subjects acquired with CBM were compared with the surgical field. Kappa tests, conclusive concordance (CC), partial concordance (PC), and discordance were estimated, with McNemar's test determining the superiority.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>After an average follow-up of 37.2 months, in people who were seizure-free (<i>n</i> = 31; functionally silent cortices in 26), the CC rate with CBM was 87.10%. Performance was CBM (CC:PC = 27:1), t-map (CC:PC = 15:1), and SUVR (CC:PC = 0:17). The sensitivity, specificity, and kappa scores were 0.87, 0.91, and 0.717 (<i>p</i> &lt; 0.001) for CBM and 0.48, 0.73, and 0.153 (<i>p</i> = 0.288) for t-maps, respectively. The CBM approach was superior to the t-map (<i>p</i> &lt; 0.001) in most extratemporal epilepsies. The average Pearson's <i>r</i> of CBM and t-map to artifacts was 0.08 ± 0.02 and 0.33 ± 0.02, respectively.</p>\n </section>\n \n <section>\n \n <h3> Interpretation</h3>\n \n <p>By eliminating intersubject morphological variations and explicit statistics at the cortex, CBM localized the seizure origin in MRI-negative epilepsy patients with superior efficiency.</p>\n </section>\n </div>","PeriodicalId":154,"journal":{"name":"CNS Neuroscience & Therapeutics","volume":"31 4","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cns.70336","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Neuroscience & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cns.70336","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Localization of the network underlying drug-resistant focal epilepsy in individuals considering surgical treatment with unremarkable MRI is challenging. Concordance rates of 40%–69% have been reported with FDG-PET image statistical parametric mapping (SPM). We investigated the efficacy of postprocessing specific to cortices by cortex-based mapping (CBM) on hybrid PET/MR images with healthy subjects to localize sites of seizure onset.

Methods

We retrospectively examined the PET/MR images of 42 MRI-negative individuals with drug-resistant focal epilepsy who had surgery and 23 healthy subjects. Visual interpretation of standardized uptake value ratios (SUVRs), voxelwise mapping with a two-sample t-test of SUVRs (t-map, SPM), and the proposed z-transformation of the SUVR of patients compared with those of healthy subjects acquired with CBM were compared with the surgical field. Kappa tests, conclusive concordance (CC), partial concordance (PC), and discordance were estimated, with McNemar's test determining the superiority.

Results

After an average follow-up of 37.2 months, in people who were seizure-free (n = 31; functionally silent cortices in 26), the CC rate with CBM was 87.10%. Performance was CBM (CC:PC = 27:1), t-map (CC:PC = 15:1), and SUVR (CC:PC = 0:17). The sensitivity, specificity, and kappa scores were 0.87, 0.91, and 0.717 (p < 0.001) for CBM and 0.48, 0.73, and 0.153 (p = 0.288) for t-maps, respectively. The CBM approach was superior to the t-map (p < 0.001) in most extratemporal epilepsies. The average Pearson's r of CBM and t-map to artifacts was 0.08 ± 0.02 and 0.33 ± 0.02, respectively.

Interpretation

By eliminating intersubject morphological variations and explicit statistics at the cortex, CBM localized the seizure origin in MRI-negative epilepsy patients with superior efficiency.

Abstract Image

18F-FDG-PET/MR混合图像在mri阴性癫痫中的定量皮质映射
目的:在考虑手术治疗且MRI表现不明显的个体中,定位耐药局灶性癫痫的神经网络具有挑战性。据报道,FDG-PET图像统计参数映射(SPM)的一致性率为40%-69%。我们通过对健康受试者的混合PET/MR图像进行基于皮质的映射(CBM),研究了特定皮质的后处理对癫痫发作部位的定位效果。方法回顾性分析42例mri阴性、手术治疗的耐药局灶性癫痫患者和23例健康人的PET/MR图像。将标准化摄取值比(SUVRs)的视觉解释、SUVRs的双样本t检验的体素映射(t-map, SPM)以及与获得CBM的健康受试者相比,患者SUVR的z转换与手术视野进行比较。Kappa检验、结论性一致性(CC)、部分一致性(PC)和不一致性进行了估计,以McNemar检验确定优势。结果平均随访37.2个月后,无癫痫发作者(n = 31;功能沉默皮质(26),CBM的CC率为87.10%。性能是煤层气(CC:电脑= 27:1),t-map (CC: PC = 15:1)和SUVR (CC: PC = 0:17)。CBM的敏感性、特异性和kappa评分分别为0.87、0.91和0.717 (p < 0.001), t-map的敏感性、特异性和kappa评分分别为0.48、0.73和0.153 (p = 0.288)。在大多数颞外癫痫中,CBM方法优于t图(p < 0.001)。CBM和t-map到伪影的平均Pearson’s r分别为0.08±0.02和0.33±0.02。通过消除受试者间的形态学差异和皮层的明确统计,CBM以优越的效率定位了mri阴性癫痫患者的发作起源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CNS Neuroscience & Therapeutics
CNS Neuroscience & Therapeutics 医学-神经科学
CiteScore
7.30
自引率
12.70%
发文量
240
审稿时长
2 months
期刊介绍: CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信